These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 33658945)
41. Diagnostic value of serum neuroactive substances in the acute exacerbation of chronic obstructive pulmonary disease complicated with depression. Duan W; Cheng M Open Life Sci; 2023; 18(1):20220693. PubMed ID: 37671095 [TBL] [Abstract][Full Text] [Related]
42. Impact of overlap syndrome on severity of acute exacerbation of chronic obstructive pulmonary disease. Gothi D; Gupta SS; Kumar N; Sood K Lung India; 2015; 32(6):578-83. PubMed ID: 26664163 [TBL] [Abstract][Full Text] [Related]
43. Exacerbation recovery patterns in newly diagnosed or maintenance treatment-naïve patients with COPD: secondary analyses of TICARI 1 trial data. Mannino DM; Clerisme-Beaty EM; Franceschina J; Ting N; Leidy NK Int J Chron Obstruct Pulmon Dis; 2018; 13():1515-1525. PubMed ID: 29785101 [TBL] [Abstract][Full Text] [Related]
44. The safety of sputum induction in adults with acute exacerbation of COPD. Gao P; Gibson PG; Zhang J; He X; Hao Y; Li P; Liu H Clin Respir J; 2013 Jan; 7(1):101-9. PubMed ID: 22452898 [TBL] [Abstract][Full Text] [Related]
45. Sputum mucin 1 is increased during the acute phase of chronic obstructive pulmonary disease exacerbation. Zheng Z; Qi Y; Xu X; Jiang H; Li Z; Yang Q; Zhang C; Zhang K; Chen R; Wang J; Lu W J Thorac Dis; 2017 Jul; 9(7):1873-1882. PubMed ID: 28839985 [TBL] [Abstract][Full Text] [Related]
46. [Risk factors analysis for one-year and long-term mortality in patients hospitalized for acute exacerbation of chronic obstructive pulmonary disease]. Zhang Y; Lin YX Zhonghua Jie He He Hu Xi Za Zhi; 2019 Dec; 42(12):895-900. PubMed ID: 31826532 [No Abstract] [Full Text] [Related]
47. [Platelet factor 4 and β-thromboglobulin in blood plasma of patients with acute exacerbation of chronic obstructive pulmonary disease]. Wu JF; Yang YH; Pang BS Zhonghua Yi Xue Za Zhi; 2013 May; 93(18):1378-82. PubMed ID: 24025501 [TBL] [Abstract][Full Text] [Related]
48. Long non-coding RNA NEAT1 predicts elevated chronic obstructive pulmonary disease (COPD) susceptibility and acute exacerbation risk, and correlates with higher disease severity, inflammation, and lower miR-193a in COPD patients. Ming X; Duan W; Yi W Int J Clin Exp Pathol; 2019; 12(8):2837-2848. PubMed ID: 31934120 [TBL] [Abstract][Full Text] [Related]
49. The association of delta neutrophil index with the prognosis of acute exacerbation of chronic obstructive pulmonary disease. Park S; Lee SJ; Shin B; Lee SJ; Kim SH; Kwon WC; Kim J; Lee MK BMC Pulm Med; 2020 Feb; 20(1):47. PubMed ID: 32075629 [TBL] [Abstract][Full Text] [Related]
50. [The role of 4-hydroxynonenal in assessment of chronic obstructive pulmonary disease severity]. Liu H; Xu JY Zhonghua Jie He He Hu Xi Za Zhi; 2012 Oct; 35(10):758-61. PubMed ID: 23289993 [TBL] [Abstract][Full Text] [Related]
51. Expression and Clinical Significance of Serum Dipeptidyl Peptidase IV Chronic Obstructive Pulmonary Disease. Chang XY; Yang Y; Jia XQ; Wang Y; Peng LN; Ai XH; Jiang CY; Guo JH; Wu TT Am J Med Sci; 2016 Mar; 351(3):244-52. PubMed ID: 26992252 [TBL] [Abstract][Full Text] [Related]
52. Obvious emphysema on computed tomography during an acute exacerbation of chronic obstructive pulmonary disease predicts a poor prognosis. Cheng T; Wan HY; Cheng QJ; Guo Y; Qian YR; Fan L; Feng Y; Song YY; Zhou M; Li QY; Shi GC; Huang SG Intern Med J; 2015 May; 45(5):517-26. PubMed ID: 25684314 [TBL] [Abstract][Full Text] [Related]
53. Effects of High-Dose Vitamin D Replacement on the Serum Levels of Systemic Inflammatory Biomarkers in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease. Dastan F; Salamzadeh J; Pourrashid MH; Edalatifard M; Eslaminejad A COPD; 2019 Aug; 16(3-4):278-283. PubMed ID: 31550915 [TBL] [Abstract][Full Text] [Related]
54. [Clinical significance of serum carbohydrate antigen 125 in acute exacerbation of chronic obstructive pulmonary disease]. Zhang M; Li YL; Yang X; Shan H; Zhang QH; Feng XL; Xie YY; Tang JJ; Zhang J Nan Fang Yi Ke Da Xue Xue Bao; 2016 Oct; 36(10):1386-1389. PubMed ID: 27777203 [TBL] [Abstract][Full Text] [Related]
55. Bronchoalveolar pH and inflammatory biomarkers in patients with acute exacerbation of chronic obstructive pulmonary disease. Lozo Vukovac E; Miše K; Gudelj I; Perić I; Duplančić D; Vuković I; Vučinović Z; Lozo M J Int Med Res; 2019 Feb; 47(2):791-802. PubMed ID: 30488761 [TBL] [Abstract][Full Text] [Related]
56. The diagnostic value of homocysteine for the occurrence and acute progression of chronic obstructive pulmonary disease. Wei B; Tian T; Liu Y; Li C BMC Pulm Med; 2020 Sep; 20(1):237. PubMed ID: 32894108 [TBL] [Abstract][Full Text] [Related]
57. Role of the DECAF Score in Predicting In-hospital Mortality in Acute Exacerbation of Chronic Obstructive Pulmonary Disease. Memon MA; Faryal S; Brohi N; Kumar B Cureus; 2019 Jun; 11(6):e4826. PubMed ID: 31403014 [TBL] [Abstract][Full Text] [Related]
58. L-Arginine Pathway in COPD Patients with Acute Exacerbation: A New Potential Biomarker. Ruzsics I; Nagy L; Keki S; Sarosi V; Illes B; Illes Z; Horvath I; Bogar L; Molnar T COPD; 2016; 13(2):139-45. PubMed ID: 26514682 [TBL] [Abstract][Full Text] [Related]
59. Fast Prediction of Deterioration and Death Risk in Patients With Acute Exacerbation of Chronic Obstructive Pulmonary Disease Using Vital Signs and Admission History: Retrospective Cohort Study. Zhou M; Chen C; Peng J; Luo CH; Feng DY; Yang H; Xie X; Zhou Y JMIR Med Inform; 2019 Oct; 7(4):e13085. PubMed ID: 31638595 [TBL] [Abstract][Full Text] [Related]
60. Monitoring Antioxidant Enzyme Activity during Exacerbations of Chronic Obstructive Pulmonary Disease. Antus B; Paska C; Simon B; Barta I COPD; 2018 Oct; 15(5):496-502. PubMed ID: 30475645 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]